50 states + Washington, D.C. · 23 city guides

Reviewed July 21, 2026 · updated Oct 18, 2026

What states are magic mushrooms legal in?

Choose a state for a concise explanation of possession law, regulated programs, local enforcement policies, and the sources used for the review.

These pages are educational summaries, not legal advice. State and local rules can change between review dates.

What states are magic mushrooms legal in? 2026 table

No U.S. state has legalized retail sale of psilocybin mushrooms. Two states run regulated frameworks, a handful have research, pilot, or local enforcement-priority policies, and the rest keep psilocybin fully controlled. Each row links to the state guide and its sources.

StateStatus (2026)Guide
ColoradoPersonal-use protections · licensed servicesOpen →
OregonLicensed supervised servicesOpen →
AlaskaControlled · initiative petition, not lawOpen →
ArizonaControlled · research funding and conditional future drug lawOpen →
CaliforniaControlled · selected local policiesOpen →
ConnecticutControlled · limited research pilotOpen →
GeorgiaControlled · conditional future drug lawOpen →
IndianaControlled · research fundOpen →
LouisianaControlled · clinical-study law effective Aug. 1, 2026Open →
MaineControlled · Schedule XOpen →
MissouriControlled · 2026 therapeutic-use proposal advanced, not enactedOpen →
NebraskaControlled · specified pharmaceutical exception onlyOpen →
New JerseyControlled · selected-hospital research pilotOpen →
New MexicoMedical program in development · not yet openOpen →
North DakotaControlled · specified pharmaceutical exception onlyOpen →
South DakotaControlled · specified drug-product exception onlyOpen →
UtahControlled · limited health-system pilot, no public accessOpen →
VermontControlled · advisory work, no current accessOpen →
WashingtonControlled · pilot and local policiesOpen →
Washington, D.C.Lowest enforcement priority · not legalOpen →
West VirginiaControlled · conditional FDA and federal triggerOpen →
AlabamaControlled · no statewide access programOpen →
ArkansasControlled · no statewide access programOpen →
DelawareControlled · no statewide access programOpen →
FloridaControlled · no statewide access programOpen →
HawaiiControlled · no statewide access programOpen →
IdahoControlled · no statewide access programOpen →
IllinoisControlled · no statewide access programOpen →
IowaControlled · no statewide access programOpen →
KansasControlled · no statewide access programOpen →
KentuckyControlled · no statewide access programOpen →
MarylandControlled · no statewide access programOpen →
MassachusettsControlled · no statewide access programOpen →
MichiganControlled · no statewide access programOpen →
MinnesotaControlled · no statewide access programOpen →
MississippiControlled · FDA-trigger pharmaceutical pathway onlyOpen →
MontanaControlled · experimental-treatment framework, no public accessOpen →
NevadaControlled · no statewide access programOpen →
New HampshireControlled · no statewide access programOpen →
New YorkControlled · no statewide access programOpen →
North CarolinaControlled · no statewide access programOpen →
OhioControlled · no statewide access programOpen →
OklahomaControlled · no statewide access programOpen →
PennsylvaniaControlled · no statewide access programOpen →
Rhode IslandControlled · no statewide access programOpen →
South CarolinaControlled · no statewide access programOpen →
TennesseeControlled · no statewide access programOpen →
TexasControlled · no statewide access programOpen →
VirginiaControlled · FDA-trigger pharmaceutical pathway onlyOpen →
WisconsinControlled · no statewide access programOpen →
WyomingControlled · no statewide access programOpen →

City guides

Nine cities have an iMicrodosing community location (by appointment) and a local microdosing guide. The rest are cities with a documented local enforcement policy.

State and district guides

AlabamaControlled · no statewide access programAlaskaControlled · initiative petition, not lawArizonaControlled · research funding and conditional future drug lawArkansasControlled · no statewide access programCaliforniaControlled · selected local policiesColoradoPersonal-use protections · licensed servicesConnecticutControlled · limited research pilotDelawareControlled · no statewide access programWashington, D.C.Lowest enforcement priority · not legalFloridaControlled · no statewide access programGeorgiaControlled · conditional future drug lawHawaiiControlled · no statewide access programIdahoControlled · no statewide access programIllinoisControlled · no statewide access programIndianaControlled · research fundIowaControlled · no statewide access programKansasControlled · no statewide access programKentuckyControlled · no statewide access programLouisianaControlled · clinical-study law effective Aug. 1, 2026MaineControlled · Schedule XMarylandControlled · no statewide access programMassachusettsControlled · no statewide access programMichiganControlled · no statewide access programMinnesotaControlled · no statewide access programMississippiControlled · no statewide access programMissouriControlled · proposal failedMontanaControlled · no statewide access programNebraskaControlled · specified pharmaceutical exception onlyNevadaControlled · no statewide access programNew HampshireControlled · no statewide access programNew JerseyControlled · selected-hospital research pilotNew MexicoMedical program in development · not yet openNew YorkControlled · no statewide access programNorth CarolinaControlled · no statewide access programNorth DakotaControlled · specified pharmaceutical exception onlyOhioControlled · no statewide access programOklahomaControlled · no statewide access programOregonLicensed supervised servicesPennsylvaniaControlled · no statewide access programRhode IslandControlled · no statewide access programSouth CarolinaControlled · no statewide access programSouth DakotaControlled · specified drug-product exception onlyTennesseeControlled · no statewide access programTexasControlled · no statewide access programUtahControlled · limited health-system pilot, no public accessVermontControlled · advisory work, no current accessVirginiaControlled · no statewide access programWashingtonControlled · pilot and local policiesWest VirginiaControlled · conditional FDA and federal triggerWisconsinControlled · no statewide access programWyomingControlled · no statewide access program

How the status is classified

Controlled

No general statewide access

Psilocybin remains controlled and no statewide consumer program was identified.

Limited change

Research, pilot, or local policy

A research program, limited pilot, conditional drug law, advisory body, proposal, or local enforcement-priority policy does not create statewide possession, retail, or service-center access.

Regulated framework

Oregon or Colorado

Oregon and Colorado have distinct supervised-service frameworks. Neither authorizes an ordinary take-home retail mushroom market.

Primary legal reference sources

Each state guide links to its controlling statutes, official bill records, agencies, courts, and local-policy records. These official federal and operating-program sources provide the nationwide baseline.

Common questions

Is psilocybin legal across the United States?

No. Federal law continues to control psilocybin, and state and local rules vary. Oregon and Colorado have distinct supervised-service frameworks. Other states may have research programs, hospital pilots, implementation-stage medical laws, conditional future drug exceptions, advisory bodies, proposals, or local enforcement-priority policies without current general public access.

Does local decriminalization make retail sale legal?

No. A local lowest-enforcement-priority policy generally does not create a licensed retail market, authorize commercial sale, or change state and federal law.

How current are these location guides?

Every location guide in this directory was reviewed through July 22, 2026. Because law can change, readers should confirm official state and local sources before relying on a summary.